NEW YORK, June 26, 2017 /PRNewswire/ -- Transvaginal mesh lawsuits filed against Johnson & Johnson and its Ethicon, Inc. subsidiary continue to move forward in a mass tort litigation now underway in Pennsylvania's Philadelphia Court of Common Pleas. According to a posting on the website for the Philadelphia Complex Litigation Center, the Court will convene a meeting on July 11th, 11:00 a.m. ET, to discuss the status of the pelvic mesh litigation. (Case ID 140200829)
"Our Firm is representing hundreds of women who were allegedly injured by Ethicon's transvaginal mesh products, and we continue to receive inquiries from prospective plaintiffs on a regular basis. We are monitoring the Pennsylvania litigation closely for any developments that could impact our clients' cases," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to investigate legal claims on behalf of women who suffered serious vaginal mesh complications, allegedly due to products marketed by Ethicon and other manufacturers.
Pennsylvania Transvaginal Mesh Litigation
Transvaginal mesh devices are implanted in women suffering from pelvic organ prolapse or stress urinary incontinence. In 2008, the U.S. Food & Drug Administration (FDA) warned that such devices had been associated with at least 1,000 reports of serious injuries and complications over a three-year period. In July 2011, the agency reported that complications related to transvaginal prolapse repair had tripled since the release of its previous warning. Among other things, the FDA reversed its stance that such injuries were rare.
In 2016, the FDA finalized regulations that reclassified pelvic mesh indicated for transvaginal prolapse repair as Class III (high risk) medical devices. The new rules also made transvaginal mesh ineligible for the agency's 510(k) clearance program, which had previously allowed such products to come to market without first undergoing human clinical trials.
Johnson & Johnson and Ethicon are named defendants in more than 55,000 transvaginal mesh lawsuits, all of which were filed on behalf of women who suffered mesh erosion, scarring and adhesions, organ damage and other serious complications due to the allegedly defective nature of these devices. Court documents indicate that 180 of these claims are pending in the Pennsylvania mass tort program. The litigation has already convened five pelvic mesh trials, with only one jury rendering a verdict for the defense. The other four trials have produced plaintiffs' verdicts of $20 million, $12.5 million, $13.5 million and $2.1 million.
Women who suffered serious complications allegedly associated with transvaginal mesh may be entitled to compensation for medical bills, lost wages, pain and suffering and more. To learn more, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no-obligation review of your potential claim.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs' firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2017 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
SOURCE Bernstein Liebhard LLP